Evaluation of aerosols of prostaglandins E1 and E2 as bronchodilators

Eur J Clin Pharmacol. 1973 Aug;6(2):127-32. doi: 10.1007/BF00562439.
No abstract available

Publication types

  • Clinical Trial

MeSH terms

  • Adult
  • Aerosols
  • Aged
  • Airway Resistance / drug effects
  • Asthma / drug therapy
  • Asthma / physiopathology
  • Blood Pressure / drug effects
  • Bronchitis / drug therapy
  • Bronchitis / physiopathology
  • Bronchodilator Agents / pharmacology*
  • Carbon Dioxide / blood
  • Clinical Trials as Topic
  • Female
  • Heart Rate / drug effects
  • Humans
  • Lung Compliance / drug effects
  • Male
  • Middle Aged
  • Oxygen / blood
  • Oxygen Consumption / drug effects
  • Plethysmography, Whole Body
  • Prostaglandins / pharmacology*
  • Prostaglandins / therapeutic use
  • Pulse / drug effects
  • Respiration / drug effects
  • Time Factors
  • Ventilation-Perfusion Ratio

Substances

  • Aerosols
  • Bronchodilator Agents
  • Prostaglandins
  • Carbon Dioxide
  • Oxygen